115 related articles for article (PubMed ID: 33042334)
1. The expression of the circadian gene TIMELESS in non-small-cell lung cancer and its clinical significance.
Zhang Y; Peng X; Yang H; Zhao H; Xia B; You Y
Int J Clin Exp Pathol; 2020; 13(9):2297-2304. PubMed ID: 33042334
[TBL] [Abstract][Full Text] [Related]
2. Association between BMP4 expression and pathology, CT characteristics and prognosis of non-small cell lung cancer.
Ju FJ; Meng FQ; Hu HL; Liu J
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5787-5794. PubMed ID: 31298330
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
4. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
5. Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: a retrospective cohort study.
Zhang C; Xu L; Ma Y; Huang Y; Zhou L; Le H; Chen Z
J Thorac Dis; 2023 Mar; 15(3):1433-1444. PubMed ID: 37065598
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.
Jin E; Wang W; Fang M; Wang W; Xie R; Zhou H; Ye J; Xu R; Ma S
Oncol Lett; 2019 Jan; 17(1):502-507. PubMed ID: 30655793
[TBL] [Abstract][Full Text] [Related]
7. Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer.
Wang Q; Zhang Y; Zhang T; Han ZG; Shan L
Onco Targets Ther; 2015; 8():1971-7. PubMed ID: 26261421
[TBL] [Abstract][Full Text] [Related]
8. Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer.
Chen KB; Xuan Y; Shi WJ; Chi F; Xing R; Zeng YC
Am J Transl Res; 2016; 8(4):1903-9. PubMed ID: 27186314
[TBL] [Abstract][Full Text] [Related]
9. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
11. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of TIM-1 expression in human non-small-cell lung cancer.
Zheng X; Xu K; Chen L; Zhou Y; Jiang J
J Transl Med; 2019 May; 17(1):178. PubMed ID: 31138322
[TBL] [Abstract][Full Text] [Related]
13. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
14. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
15. [Expression of FATS in non-small cell lung cancer and its relationship with prognosis].
Zhang TM; Zhang J; Zhou DJ; Wang CL
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):826-830. PubMed ID: 31770849
[No Abstract] [Full Text] [Related]
16. Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Sun Y; Li D; Lv XH; Hua SC; Han JC; Xu F; Li XD
J Res Med Sci; 2015 Dec; 20(12):1138-46. PubMed ID: 26958047
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
18. Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.
Cai Q; Huang Z; Qi L; Wang T; Shen Y; Huang J
Oncol Lett; 2016 Oct; 12(4):2680-2685. PubMed ID: 27698842
[TBL] [Abstract][Full Text] [Related]
19. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
20. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
